These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response. Adcock IM; Cosio B; Tsaprouni L; Barnes PJ; Ito K Antioxid Redox Signal; 2005; 7(1-2):144-52. PubMed ID: 15650403 [TBL] [Abstract][Full Text] [Related]
6. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Rahman I; Marwick J; Kirkham P Biochem Pharmacol; 2004 Sep; 68(6):1255-67. PubMed ID: 15313424 [TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and redox regulation of lung inflammation in COPD. Rahman I; Adcock IM Eur Respir J; 2006 Jul; 28(1):219-42. PubMed ID: 16816350 [TBL] [Abstract][Full Text] [Related]
8. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Barnes PJ; Adcock IM; Ito K Eur Respir J; 2005 Mar; 25(3):552-63. PubMed ID: 15738302 [TBL] [Abstract][Full Text] [Related]
9. Impact of protein acetylation in inflammatory lung diseases. Ito K; Charron CE; Adcock IM Pharmacol Ther; 2007 Nov; 116(2):249-65. PubMed ID: 17720252 [TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells. Moodie FM; Marwick JA; Anderson CS; Szulakowski P; Biswas SK; Bauter MR; Kilty I; Rahman I FASEB J; 2004 Dec; 18(15):1897-9. PubMed ID: 15456740 [TBL] [Abstract][Full Text] [Related]
11. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Barnes PJ Proc Am Thorac Soc; 2009 Dec; 6(8):693-6. PubMed ID: 20008877 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms and resistance in glucocorticoid control of inflammation. Barnes PJ J Steroid Biochem Mol Biol; 2010 May; 120(2-3):76-85. PubMed ID: 20188830 [TBL] [Abstract][Full Text] [Related]
15. Impact of post-translational modifications of proteins on the inflammatory process. Ito K Biochem Soc Trans; 2007 Apr; 35(Pt 2):281-3. PubMed ID: 17371260 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid pathways in chronic obstructive pulmonary disease therapy. Adcock IM; Ito K Proc Am Thorac Soc; 2005; 2(4):313-9; discussion 340-1. PubMed ID: 16267355 [TBL] [Abstract][Full Text] [Related]
17. Histone deacetylation: an important mechanism in inflammatory lung diseases. Adcock IM; Ito K; Barnes PJ COPD; 2005 Dec; 2(4):445-55. PubMed ID: 17147010 [TBL] [Abstract][Full Text] [Related]
19. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. Mroz RM; Noparlik J; Chyczewska E; Braszko JJ; Holownia A J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):453-60. PubMed ID: 18204158 [TBL] [Abstract][Full Text] [Related]
20. The role of histone deacetylases in asthma and allergic diseases. Bhavsar P; Ahmad T; Adcock IM J Allergy Clin Immunol; 2008 Mar; 121(3):580-4. PubMed ID: 18234319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]